# Curcumin, the Bioactive Compound of Turmeric, Boosts Cellular Antioxidant Defense via the miR-22-3p/MCAT Axis

**Authors:** Haiqi Wang, Yanqi Lin, Yuanyuan Li, Shiying Huang, Guiling Li

PMC · DOI: 10.3390/foods15040670 · Foods · 2026-02-12

## TL;DR

Curcumin boosts cellular antioxidant defenses by regulating a microRNA and mitochondrial enzyme in liver cells.

## Contribution

A novel miR-22-3p/MCAT pathway through which curcumin enhances antioxidant activity is identified.

## Key findings

- Curcumin downregulates miR-22-3p, a stress-responsive microRNA.
- MCAT is a direct target of miR-22-3p and contributes to curcumin's antioxidant effects.
- Modulation of the miR-22-3p/MCAT axis reduces ROS and improves mitochondrial function.

## Abstract

Curcumin, the major bioactive polyphenol derived from the edible rhizome turmeric (Curcuma longa L.), is recognized for its health-promoting properties. Despite well-documented antioxidant effects, its molecular mechanisms, particularly those involving post-transcriptional regulation, remain incompletely understood. This in vitro study identifies a novel microRNA-mediated pathway contributing to the antioxidant activity of curcumin in human hepatic LO2 cells. Curcumin treatment downregulated the stress-responsive microRNA miR-22-3p. Bioinformatics analysis and a dual-luciferase reporter assay identified malonyl-CoA-acyl carrier protein transacylase (MCAT), a mitochondrial enzyme, as a direct target of miR-22-3p. Modulation of this axis reduced intracellular reactive oxygen species (ROS), enhanced total reducing capacity, increased activities of key antioxidant enzymes (SOD, CAT, GPx), and improved mitochondrial bioenergetics without altering membrane potential. Crucially, siRNA-mediated knockdown of MCAT attenuated the ROS-scavenging effect of curcumin. These findings reveal a mechanistic pathway wherein curcumin downregulates miR-22-3p, resulting in upregulation of MCAT and enhanced mitochondrial antioxidant defense. This work broadens the understanding of curcumin’s bioactivity from direct radical scavenging to include the post-transcriptional fine-tuning of mitochondrial metabolism. The study establishes a molecular framework for further exploration of curcumin’s potential in alleviating oxidative stress.

## Linked entities

- **Genes:** MCAT (malonyl-CoA-acyl carrier protein transacylase) [NCBI Gene 27349]
- **Proteins:** SOD1 (superoxide dismutase 1), CAT (catalase), GPX (probable phospholipid hydroperoxide glutathione peroxidase), MCAT (malonyl-CoA-acyl carrier protein transacylase)
- **Chemicals:** curcumin (PubChem CID 969516)

## Full-text entities

- **Genes:** SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, CAT (catalase) [NCBI Gene 847], MCAT (malonyl-CoA-acyl carrier protein transacylase) [NCBI Gene 27349] {aka FASN2C, MCT, MCT1, MT, NET62, OPA15}, MIR223 (microRNA 223) [NCBI Gene 407008] {aka MIRN223, miRNA223, mir-223}, MIR146A (microRNA 146a) [NCBI Gene 406938] {aka MIRN146, MIRN146A, miR-146a, miRNA146A}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, MMUT (methylmalonyl-CoA mutase) [NCBI Gene 4594] {aka MCM, MUT}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}
- **Diseases:** NAFLD (MESH:D065626), mitochondrial (MESH:D028361), injury to (MESH:D014947), metabolic and neurodegenerative disorders (MESH:D019636), inflammatory (MESH:D007249), metabolic diseases (MESH:D008659), fatty liver (MESH:D005234)
- **Chemicals:** GSSG (MESH:D019803), fatty acid (MESH:D005227), Lipofectamine (MESH:C086724), peroxides (MESH:D010545), JC-1 (MESH:C068624), penicillin (MESH:D010406), superoxide (MESH:D013481), DMEM (-), H2O2 (MESH:D006861), Cur (MESH:D003474), cumene hydroperoxide (MESH:C007164), DMSO (MESH:D004121), ROS (MESH:D017382), PBS (MESH:D007854), lipid (MESH:D008055), ABTS (MESH:C002502), polyphenol (MESH:D059808), ATP (MESH:D000255), TPTZ (MESH:C002849), GSH (MESH:D005978), CO2 (MESH:D002245), ADP (MESH:D000244), streptomycin (MESH:D013307), xanthine (MESH:D019820), 5,5'-dithio-bis-(2-nitrobenzoic acid) (MESH:D004228), 2',7'-dichlorofluorescein diacetate (MESH:C029569), TRIzol (MESH:C411644), tetrazolium salt (MESH:D013778), water (MESH:D014867), curcuminoid (MESH:D036381), MitoSOX  Red (MESH:C000597839)
- **Species:** Homo sapiens (human, species) [taxon 9606], Curcuma longa (turmeric, species) [taxon 136217]
- **Cell lines:** LO2 — Homo sapiens (Human), Amelanotic melanoma, Cancer cell line (CVCL_C7SD)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939168/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939168/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939168/full.md

---
Source: https://tomesphere.com/paper/PMC12939168